ProMIS Neurosciences PMN
NASDAQ PMN
$8.34 -0.68 (-7.54%)
At close: Oct 23, 2026 · 4:00 PM EDT

ProMIS Neurosciences (PMN) Amortization of Deferred Charges (2021 - 2022)

Updated

Analysis

ProMIS Neurosciences (PMN) Amortization of Deferred Charges (2021 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 ProMIS Neurosciences 74.79 Mn -64.10 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -5,192.00
Sep 30, 2022 -3,014.00
Mar 31, 2022 130,563.00
Dec 31, 2021 124,460.00
Sep 30, 2021 144,154.00
API Access

ProMIS Neurosciences Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=PMN&period=max&api_key=YOUR_API_KEY